Follow
Eurocine Vaccines AB
Spotlight (Sweden)
Eurocine Vaccines is a pharmaceutical company. Today, the company develops vaccines for the treatment of influenza. The vaccine may be used by both adults and children and is applied through nasal drops rather than needle sticks. The products are sold under separate trademarks, and the largest business is found in the Nordic market, where research is carried out in cooperation with other companies in the industry. The head office is located in Solna.
Sector:
HEALTH CARE
Exercise
Price
0.087 SEK
Exercise period(s)
01 Jun - 12 Jun 2020
View Details
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0001839069
Spotlight
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
511 092 893
Par value
0.0025
Market cap
63 400 000.00 SEK
Currency
SEK
First trading date
12 Dec 2006
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
4.80 SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Market
Spotlight
Subscription period
16 Oct - 13 Nov 2006
Subscription price
Price per share
4.80 SEK
Target to raise
15 000 000 SEK
Types
Pre-money valuation
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Dec 2006
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
16.00 SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
11 Oct - 26 Oct 2007
Subscription price
Price per share
16.00 SEK
Target to raise
27 100 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:4.
Type
Price
Pre-money valuation
Time
Files
New issue
23.00 SEK
194.6M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
19 Feb - 05 Mar 2010
Subscription price
Price per share
23.00 SEK
Target to raise
9 731 000 SEK
Types
Share issue
Pre-money valuation
194 600 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:20.
Type
Price
Pre-money valuation
Time
Files
New issue
19.00 SEK
168.8M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
17 Jan - 31 Jan 2011
Subscription price
Price per share
19.00 SEK
Target to raise
21 100 000 SEK
Types
Share issue
Pre-money valuation
168 800 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:8.
Type
Price
Pre-money valuation
Time
Files
New issue
17.00 SEK
180M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
01 Jun - 15 Jun 2012
Subscription price
Price per share
17.00 SEK
Target to raise
30 000 000 SEK
Types
Share issue
Pre-money valuation
180 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:6.
Type
Price
Pre-money valuation
Time
Files
New issue
6.50 SEK
77.3M SEK
11 Feb - 11 Feb 2014
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
11 Feb - 11 Feb 2014
Subscription price
Price per share
6.50 SEK
Target to raise
7 650 000 SEK
Types
Share issue
Pre-money valuation
77 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to an unnamed American institutional investor.
Type
Price
Pre-money valuation
Time
Files
New issue
2.65 SEK
35M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
14 Apr - 28 Apr 2015
Subscription price
Price per share
2.65 SEK
Target to raise
23 100 000 SEK
Types
Share issue
Pre-money valuation
35 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:3.
Type
Price
Pre-money valuation
Time
Files
New issue
1.10 SEK
24M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
25 Feb - 09 Mar 2016
Subscription price
1.10 SEK
Price per share
1.10 SEK
Target to raise
18 000 000 SEK
Types
Share issue
Pre-money valuation
24 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:4. Shareholders in Eurocine Vaccines receive one (1) unit right for each existing share that the owner holds in the Company. Four (4) unit rights entitle to subscribe for three (3) units. Each unit consists of one (1) newly issued share and one (1) newly issued warrant.
Type
Price
Pre-money valuation
Time
Files
Exercise
17 Oct - 28 Oct 2016
-
Option exercise terms for EUCI TO 1
Market
Spotlight
Exercise period(s)
17 Oct - 28 Oct 2016
Exercise price
Status
Closed
Issue terms
Final price will be calculated based on 70% from average trading volume on period 03.10.2016-14.10.2016
Type
Price
Pre-money valuation
Time
Files
New issue
2.34 SEK
125.1M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
28 Nov - 12 Dec 2017
Subscription price
2.34 SEK
Price per share
2.34 SEK
Target to raise
41 700 000 SEK
Types
Share issue
Pre-money valuation
125 100 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. For each 1 share held, 1 unit right is received. 3 unit rights gives the right to subscribe for 1 new unit. 1 unit consists of 1 share and 1 warrant.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.24 SEK
26 Nov - 07 Dec 2018
-
Option exercise terms for EUCI TO 2
Market
Spotlight
Exercise period(s)
26 Nov - 07 Dec 2018
Exercise price
0.24 SEK
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
0.24 SEK
20 Dec - 20 Dec 2018
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
20 Dec - 20 Dec 2018
Subscription price
0.24 SEK
Price per share
0.24 SEK
Target to raise
3 300 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to VisMederi Srl. Payment by set-off.
Type
Price
Pre-money valuation
Time
Files
New issue
0.11 SEK
9.4M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
25 Mar - 08 Apr 2019
Subscription price
0.11 SEK
Price per share
0.11 SEK
Target to raise
15 600 000 SEK
Types
Share issue
Pre-money valuation
9 400 000 SEK
Subscription block size
Minimum subscription
Record date
21 Mar 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 5:3. Each existing share entitles one (1) subscription right and three (3) subscription rights entitle to subscribe for five (5) new shares.
Type
Price
Pre-money valuation
Time
Files
New issue
0.1187 SEK
25.2M SEK
14 Oct 2019
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription date
14 Oct 2019
Subscription price
Price per share
0.1187 SEK
Target to raise
2 400 000 SEK
Types
Share issue
Pre-money valuation
25 200 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Issue directed to Fårö Capital AB and Eastbridge Capital AB.
Comments for offer & related information
Eurocine loans also take out a bridge loan of SEK 2 million from Formue Nord Markedsneutral A / S. The loan runs until it is repaid, but as long as March 31, 2020. The loan runs at a monthly interest rate of 2.5 percent for each 30-day period started. Accrued interest is not cumulative (so-called "interest on interest").
Type
Price
Pre-money valuation
Time
Files
New issue
0.053 SEK
12.3M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
21 Jan - 04 Feb 2020
Subscription price
0.318 SEK
Price per share
0.053 SEK
Target to raise
14 775 000 SEK
Types
Share issue
Pre-money valuation
12 300 000 SEK
Subscription block size
Minimum subscription
Record date
16 Jan 2020
Offer status
Closed
Listing status
Listed
Issue terms
Preference 6:5. One (1) existing share entails the acquisition of one (1) unit right. Possession of five (5) unit rights entitles to subscribe for one (1) new unit. One (1) unit consists of six (6) shares and six (6) warrants of series TO 3. The warrants are issued free of charge.
Comments for offer & related information
The company shall issue a maximum of 46 462 990 units. Prior to the rights issue, board members and the CEO of the company have entered into agreements on subscription commitments totaling approximately SEK 170 thousand. In addition, Eurocine Vaccines has signed a guarantee agreement (top-down) with two external parties for a total of approximately SEK 3 million. In total, Eurocine Vaccines has thus obtained subscription links and guarantee subscriptions (top-down) corresponding to approximately 21 percent of the issue volume. Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription. The subscription of shares supported by warrants of the TO 3 series can take place during the period 1 - 12 June 2020.
Type
Ticker
ISIN
Market
OPTION
EUCI TO 3
SE0013668258
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 3
Status
Active
Order book id
5XU4
Amount of instruments
278 777 940
Market cap
Currency
SEK
Trading period
04 Mar 2020 - 10 Jun 2020
Terms
Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO 3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for the exercise period for subscription options of series TO 3.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO 3
Market
Spotlight
Exercise period(s)
01 Jun - 12 Jun 2020
Exercise price
0.087 SEK
Status
Active
 
Issue terms
Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO 3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for the exercise period for subscription options of series TO 3.
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0001839069
Spotlight
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
511 092 893
Par value
0.0025
Market cap
63 400 000.00 SEK
Currency
SEK
First trading date
12 Dec 2006
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
4.80 SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Market
Spotlight
Subscription period
16 Oct - 13 Nov 2006
Subscription price
Price per share
4.80 SEK
Target to raise
15 000 000 SEK
Types
Pre-money valuation
Subscription block size
Minimum subscription
1 000
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Dec 2006
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
16.00 SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
11 Oct - 26 Oct 2007
Subscription price
Price per share
16.00 SEK
Target to raise
27 100 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
200
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:4.
Type
Price
Pre-money valuation
Time
Files
New issue
23.00 SEK
194.6M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
19 Feb - 05 Mar 2010
Subscription price
Price per share
23.00 SEK
Target to raise
9 731 000 SEK
Types
Share issue
Pre-money valuation
194 600 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preference right 1:20.
Type
Price
Pre-money valuation
Time
Files
New issue
19.00 SEK
168.8M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
17 Jan - 31 Jan 2011
Subscription price
Price per share
19.00 SEK
Target to raise
21 100 000 SEK
Types
Share issue
Pre-money valuation
168 800 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:8.
Type
Price
Pre-money valuation
Time
Files
New issue
17.00 SEK
180M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
01 Jun - 15 Jun 2012
Subscription price
Price per share
17.00 SEK
Target to raise
30 000 000 SEK
Types
Share issue
Pre-money valuation
180 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:6.
Type
Price
Pre-money valuation
Time
Files
New issue
6.50 SEK
77.3M SEK
11 Feb - 11 Feb 2014
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
11 Feb - 11 Feb 2014
Subscription price
Price per share
6.50 SEK
Target to raise
7 650 000 SEK
Types
Share issue
Pre-money valuation
77 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to an unnamed American institutional investor.
Type
Price
Pre-money valuation
Time
Files
New issue
2.65 SEK
35M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
14 Apr - 28 Apr 2015
Subscription price
Price per share
2.65 SEK
Target to raise
23 100 000 SEK
Types
Share issue
Pre-money valuation
35 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:3.
Type
Price
Pre-money valuation
Time
Files
New issue
1.10 SEK
24M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
25 Feb - 09 Mar 2016
Subscription price
1.10 SEK
Price per share
1.10 SEK
Target to raise
18 000 000 SEK
Types
Share issue
Pre-money valuation
24 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:4. Shareholders in Eurocine Vaccines receive one (1) unit right for each existing share that the owner holds in the Company. Four (4) unit rights entitle to subscribe for three (3) units. Each unit consists of one (1) newly issued share and one (1) newly issued warrant.
Type
Price
Pre-money valuation
Time
Files
New issue
2.34 SEK
125.1M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
28 Nov - 12 Dec 2017
Subscription price
2.34 SEK
Price per share
2.34 SEK
Target to raise
41 700 000 SEK
Types
Share issue
Pre-money valuation
125 100 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:3. For each 1 share held, 1 unit right is received. 3 unit rights gives the right to subscribe for 1 new unit. 1 unit consists of 1 share and 1 warrant.
Type
Price
Pre-money valuation
Time
Files
New issue
0.24 SEK
20 Dec - 20 Dec 2018
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
20 Dec - 20 Dec 2018
Subscription price
0.24 SEK
Price per share
0.24 SEK
Target to raise
3 300 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed to VisMederi Srl. Payment by set-off.
Type
Price
Pre-money valuation
Time
Files
New issue
0.11 SEK
9.4M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
25 Mar - 08 Apr 2019
Subscription price
0.11 SEK
Price per share
0.11 SEK
Target to raise
15 600 000 SEK
Types
Share issue
Pre-money valuation
9 400 000 SEK
Subscription block size
Minimum subscription
Record date
21 Mar 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 5:3. Each existing share entitles one (1) subscription right and three (3) subscription rights entitle to subscribe for five (5) new shares.
Type
Price
Pre-money valuation
Time
Files
New issue
0.1187 SEK
25.2M SEK
14 Oct 2019
-
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription date
14 Oct 2019
Subscription price
Price per share
0.1187 SEK
Target to raise
2 400 000 SEK
Types
Share issue
Pre-money valuation
25 200 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Issue directed to Fårö Capital AB and Eastbridge Capital AB.
Comments for offer & related information
Eurocine loans also take out a bridge loan of SEK 2 million from Formue Nord Markedsneutral A / S. The loan runs until it is repaid, but as long as March 31, 2020. The loan runs at a monthly interest rate of 2.5 percent for each 30-day period started. Accrued interest is not cumulative (so-called "interest on interest").
Type
Price
Pre-money valuation
Time
Files
New issue
0.053 SEK
12.3M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Market
Spotlight
Subscription period
21 Jan - 04 Feb 2020
Subscription price
0.318 SEK
Price per share
0.053 SEK
Target to raise
14 775 000 SEK
Types
Share issue
Pre-money valuation
12 300 000 SEK
Subscription block size
Minimum subscription
Record date
16 Jan 2020
Offer status
Closed
Listing status
Listed
Issue terms
Preference 6:5. One (1) existing share entails the acquisition of one (1) unit right. Possession of five (5) unit rights entitles to subscribe for one (1) new unit. One (1) unit consists of six (6) shares and six (6) warrants of series TO 3. The warrants are issued free of charge.
Comments for offer & related information
The company shall issue a maximum of 46 462 990 units. Prior to the rights issue, board members and the CEO of the company have entered into agreements on subscription commitments totaling approximately SEK 170 thousand. In addition, Eurocine Vaccines has signed a guarantee agreement (top-down) with two external parties for a total of approximately SEK 3 million. In total, Eurocine Vaccines has thus obtained subscription links and guarantee subscriptions (top-down) corresponding to approximately 21 percent of the issue volume. Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription. The subscription of shares supported by warrants of the TO 3 series can take place during the period 1 - 12 June 2020.
Type
Ticker
ISIN
Market
OPTION
EUCI TO 1
SE0008092555
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Final price will be calculated based on 70% from average trading volume on period 03.10.2016-14.10.2016
Type
Price
Pre-money valuation
Time
Files
Exercise
17 Oct - 28 Oct 2016
-
Option exercise terms for EUCI TO 1
Market
Spotlight
Exercise period(s)
17 Oct - 28 Oct 2016
Exercise price
Status
Closed
Issue terms
Final price will be calculated based on 70% from average trading volume on period 03.10.2016-14.10.2016
Type
Ticker
ISIN
Market
OPTION
EUCI TO 2
SE0010599878
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 2
Status
Archived
Order book id
4683
Amount of instruments
1
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
0.24 SEK
26 Nov - 07 Dec 2018
-
Option exercise terms for EUCI TO 2
Market
Spotlight
Exercise period(s)
26 Nov - 07 Dec 2018
Exercise price
0.24 SEK
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
EUCI TO 3
SE0013668258
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 3
Status
Active
Order book id
5XU4
Amount of instruments
278 777 940
Market cap
Currency
SEK
Trading period
04 Mar 2020 - 10 Jun 2020
Terms
Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO 3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for the exercise period for subscription options of series TO 3.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO 3
Market
Spotlight
Exercise period(s)
01 Jun - 12 Jun 2020
Exercise price
0.087 SEK
Status
Active
 
Issue terms
Each subscription option of the TO 3 series entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO 3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for the exercise period for subscription options of series TO 3.
People
Hans Arwidsson
CEO
Pierre Morgon
Chairman of the board
Emanuele Montomoli
Board member
Hans Arwidsson
Board member
Jan Sandström
Board member
Pär Thuresson
Board member
Company Details
Sector
HEALTH CARE

Address
Fogdevreten 2 A
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
556566-4298
LEI code
549300B408R6FTXR0D15
First trade date
12 Dec 2006
Registration date
15 Feb 1999
Short name
Eurocine Vaccines

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date